IN.PACT Japan: DCB more effective than PTA at 3 years - Healio

IN.PACT Japan: DCB more effective than PTA at 3 years  Healio

In a Japanese population, a drug-coated balloon conferred better primary patency and similar safety compared with percutaneous transluminal angioplasty at 3 ...



Comments

Post a Comment

Popular posts from this blog

Orchestra BioMed™ Announces FDA Breakthrough Device Designation for Virtue® Sirolimus-Eluting Balloon for Treatment of Below-the-Knee Peripheral Artery Disease - Vascular Disease Management

Orchestra BioMed™ Announces FDA Breakthrough Device Designation for Virtue® Sirolimus-Eluting Balloon for Treatment of Below-the-Knee Peripheral Artery Disease    Vascular Disease Management First and only non-coated sirolimus-eluting angioplasty balloon system to receive Breakthrough Device designation for below-the-knee disease; Follows ...
Read more